AptaBio Therapeutics Market Cap

AptaBio Therapeutics has a market cap or net worth of 233.18 billion as of April 28, 2026. Its market cap has increased by 15.35% in one year.

Market Cap

233.18B

Enterprise Value

220.41B

Revenue

3.70B

Ranking

n/a

PE Ratio

n/a

Stock Price

8,280.00

Market Cap Chart

Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 233.18B, a decrease of -44.91%. That is a compound annual growth rate of -8.30%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	230.93B	-8.12%
Dec 30, 2025	251.34B	46.78%
Dec 30, 2024	171.23B	-15.15%
Dec 28, 2023	201.80B	-15.02%
Dec 29, 2022	237.48B	-71.24%
Dec 30, 2021	825.71B	46.50%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Suheung	218.94B
Ilyang Pharmaceutical Co.,Ltd	212.23B
SAMSUNG PHARM. Co., LTD.	204.71B
Samjin Pharmaceuticals	232.04B
Samil Pharmaceutical Co.,Ltd	203.59B
Jeil Pharmaceutical Co.,Ltd	202.54B
Daewon Pharmaceutical	234.27B
REYON Pharmaceutical	201.38B

Market Cap Rankings